Clinical meaning
Blood glucose regulation is a tightly controlled homeostatic process essential for cellular energy production and survival. Glucose is the primary energy substrate for the brain and central nervous system, which cannot store significant glycogen reserves and depends on a continuous supply from the bloodstream. Normal fasting blood glucose ranges from 3.9 to 5.5 mmol/L (70-100 mg/dL), and postprandial glucose should remain below 7.8 mmol/L (140 mg/dL) at 2 hours. Glucose homeostasis involves two primary pancreatic hormones with opposing actions: insulin (produced by beta cells in the islets of Langerhans) lowers blood glucose, while glucagon (produced by alpha cells) raises blood glucose. When blood glucose rises after a meal, beta cells sense the increase through GLUT2 glucose transporters and glucokinase enzymes. This triggers a cascade: increased ATP production closes ATP-sensitive potassium channels, causing membrane depolarization, opening voltage-gated calcium channels, and stimulating insulin granule exocytosis. Insulin binds to tyrosine kinase receptors on target cells (primarily muscle, liver, and adipose tissue), activating intracellular signaling cascades that translocate GLUT4 glucose transporters to the cell membrane, allowing glucose uptake. Insulin also stimulates glycogen synthesis in liver and muscle, lipogenesis in adipose tissue, and protein synthesis. In the fasting state, falling glucose levels stimulate glucagon release from alpha cells. Glucagon activates hepatic glycogenolysis (breakdown of stored glycogen to glucose) and gluconeogenesis (synthesis of new glucose from amino acids, lactate, and glycerol), raising blood glucose. In type 1 diabetes mellitus, autoimmune destruction of beta cells results in absolute insulin deficiency, requiring exogenous insulin replacement. In type 2 diabetes mellitus, insulin resistance at the cellular level (impaired receptor signaling and GLUT4 translocation) combined with progressive beta cell dysfunction leads to relative insulin deficiency. Hypoglycemia (blood glucose below 3.9 mmol/L or 70 mg/dL) triggers the counter-regulatory hormone response: epinephrine and norepinephrine cause tachycardia, tremor, diaphoresis, and anxiety (adrenergic symptoms); cortisol and growth hormone contribute to longer-term glucose restoration. Severe hypoglycemia (below 2.8 mmol/L or 50 mg/dL) causes neuroglycopenic symptoms (confusion, seizures, loss of consciousness) because the brain is being deprived of its primary fuel. Hyperglycemia leads to osmotic diuresis (glucose exceeds the renal threshold of approximately 10 mmol/L or 180 mg/dL, drawing water into the urine), causing polyuria, polydipsia, and dehydration. Sustained hyperglycemia causes protein glycation and oxidative stress, damaging blood vessels (microvascular: retinopathy, nephropathy, neuropathy; macrovascular: coronary artery disease, stroke, peripheral vascular disease).